ModifyHealth, a US-based food-as-medicine platform providing medically customised meals and nutritional counselling, has secured $13.5m in a Series C funding round.
The Series C financing round was led by the Dohmen Company Foundation (DCF), through its Dohmen Impact Investment Fund.
Other participants include existing investors, RC Capital (RCC) and Nashville Capital Network (NCN).
ModifyHealth intends to use the new funding to advance its growth, implement technology advancements and enhance operations to deliver advanced food-as-medicine solutions.
The company aims to widen its reach and expand its capabilities to address chronic disease through advanced, nutrition-based management solutions.
Dohmen Company Foundation president and CEO Rachel Roller said: “Dohmen Company Foundation is pleased to welcome ModifyHealth as our newest partner in the fight against diet-related disease.
“ModifyHealth’s commitment to making food-as-medicine simple, accessible, and sustainable aligns seamlessly with our mission.
“Together, we’re not only expanding access to nutrition solutions but also empowering individuals to take control of their health.
“This partnership bridges the gap between knowing and doing, making healthy eating a sustainable reality for more people nationwide.”
ModifyHealth offers a turnkey food-as-medicine solution for chronic conditions such as type 2 diabetes, hypertension, kidney disease, obesity, and irritable bowel syndrome.
It offers customisable meal plans, including Low-FODMAP, Mediterranean, and gluten-free options, are carefully crafted to support the management of various health conditions.
In addition to customised meals, the company offers live nutrition coaching and digitally enabled education, supporting individuals in making lasting health changes.
ModifyHealth founder and CEO GB Pratt said: “This partnership represents a significant milestone in our goal to make telenutrition and medically tailored meal support a standard of care – perfectly complementing their mission to eliminate diet-related diseases.
“This investment, along with additional support from our existing partners, enables us to expand our reach, enhance our technology, and provide more people with the tools they need to manage and improve their health.
“Together, we’re demonstrating that nutrition can be a powerful tool in managing – and even reversing – chronic conditions.”
